Latest KFF Health News Content

Latest KFF Health News Stories

FDA Expected To Issue Its First Approval For A Peanut Allergy Treatment

Morning Briefing

The drug, Palforzia, is taken daily in a regimen known as oral immunotherapy that aims to blunt the immune system’s overreaction to peanuts. Though the treatment is not a cure and doesn’t work for everyone, a panel of experts recommended that the Food and Drug Administration OK the drug. A decision could come by January. In other news from the FDA: more blood pressure medicines are recalled.

‘Ticking Time Bomb’: Cases Of Mumps Among Detained Immigrants Along U.S. Border Jump From Five To 900

Morning Briefing

By keeping the immigrants in confined spaces, more are being exposed to infectious diseases like mumps and measles, health officials say. News also focuses on the mental health damage that can emerge years after children are released from detention facilities.

Public Health Officials Hopeful That New Drug Regimen May Curb The Scourge Of Tuberculosis

Morning Briefing

A course of drugs, lasting just one month, is effective at preventing the infection, scientists have reported. Also in the news: a possible new option to fight heart disease, the mysteries of chronic pain and an Alzheimer’s researcher fights a disease that threatens her husband.

U.S. Prosecutors Open Criminal Probe Of Juul; Vaping Death Toll Rises To 9

Morning Briefing

The investigation by the U.S. attorney’s office of the Northern District of California is in its early stages and the focus was not yet clear, according to The Wall Street Journal. Meanwhile, officials in Kansas tied the death of a man over the age of 50 with the vaping illnesses reported around the country. Also in the news, a look at how Wisconsin health officials zeroed in on the problem and how Sen. Dick Durbin (D-Ill.) is pushing federal officials to crack down on vaping products.

Judges Hear Appeal Challenging Trump Administration’s Abortion Funding Rule

Morning Briefing

A panel of 11 judges for the 9th U.S. Circuit Court of Appeals in San Francisco heard arguments Monday on the regulation. It bans clinics funded by the Title X federal family planning program from making abortion referrals unless the woman’s life is in danger. The lawsuit challenging the rule is backed by 22 states as well as Planned Parenthood and other organizations.

On The Campaign Trail, Warren Faces Pressure From Rivals To Detail How She’d Pay For Medicare For All

Morning Briefing

Polling done by a firm associated with the presidential campaign of former Vice President Joe Biden found the issue of “Medicare for All” to be a weak spot among Democratic primary voters. Still, a Washington Post fact check found that Biden bungled an effort to attack the policy.

Drugmakers, Facing ‘Stiffest Political Headwinds,’ Mount Strong Lobbying Effort In Congress

Morning Briefing

As both Democrats and Republicans call for new policies to curb drug prices, the pharmaceutical industry is spending millions of dollars on advertising campaigns. Some of the key lawmakers handling a Democratic proposal have received large donations from drugmakers, and Republican legislators are looking for guidance from the White House.

Challenges To Georgia, Tennessee Abortion Restrictions Go To Court

Morning Briefing

During the first day of action, opponents of Georgia’s new anti-abortion law — that effectively bans the procedure once a fetal heartbeat can be detected — argued for a federal judge to block the measure from going into effect on Jan. 1. In Tennessee, a former medical director of Planned Parenthood of Tennessee and North Mississippi testified on the state’s new 48-hour waiting period.

¿Cómo prevenir suicidios? Busca pistas en moteles, consultorios y refugios de animales

KFF Health News Original

Un programa en un condado de Oregon ha logrado reducir la tasa de suicidios investigando las decisiones que toman las personas que piensan en el suicidio días antes de cometerlo.

Legal Challenge To Georgia’s ‘Heartbeat Bill’ To Kick Off In Court

Morning Briefing

A federal judge is set to hear the arguments Monday from opponents of Georgia’s new anti-abortion law who want him to stop the measure from going into effect on Jan. 1 with the court case ongoing. Meanwhile, in Tennessee, a lawsuit challenging that state’s 48-hour waiting period is also scheduled to start.

Jury Selection To Start In California’s Antitrust Lawsuit Against Sutter Health

Morning Briefing

California’s Department of Justice alleges that Sutter Health bought up competing medical providers in Northern California and used that market dominance to increase prices for insurance plans. Sutter recently released a statement defending its business practices. The trial is expected to run for months. And other hospital and industry news is reported from Pennsylvania, Michigan, New Hampshire, Virginia, Tennessee and Georgia.

Fierce Behind-The-Scenes Fight Over California’s Vaccine Law Centered On Governor

Morning Briefing

The Los Angeles Times reports on the months of negotiating and lobbying that took place outside of the public view and shifted Calif. Gov. Gavin Newsom’s position over the course of the vaccine law debate. Other vaccine news is reported out of New York, Maryland and Oregon.

Lack Of Urgency: Former U.S. Senator Discusses Surprise About Early Failures By Congress To Fight Rise Of Fentanyl Deaths

Morning Briefing

Meanwhile, The Baltimore Sun reports that while deaths from opioids dropped overall in Maryland, Baltimore has been largely left behind. News about the opioid crisis is on litigation against the the drug makers and distributors and misinformation about anti-overdose medication, as well.